Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression
T-prolymphocytic leukemia (T-PLL) typically presents with rapidly progressing tumor burden. However, 15-25% of cases are diagnosed at an indolent stage with asymptomatic and stable low-level blood lymphocytosis over up to 2-3 years before advancing to active-stage disease. To define the molecular changes underlying this transition, we perform single-cell RNA sequencing of 28 treatment-naïve samples including 11 longitudinally acquired indolent/active pairs, paralleled by longitudinal whole genome sequencing. This reveals both patient-specific lesions and common global alterations of gene expression. Strong upregulations of MYC-target gene signatures in active T-PLL samples associated with enhanced energy metabolism implicate acquired autonomy from energetic restrictions. Recurrent downregulation of genes of the T-cell-receptor signaling cascade and reduced interactions of the T-PLL cell with non-leukemic cell types further indicate progressive independence from regulatory survival signals and escape from micromilieu-mediated control. This single-cell and disease-stage resolved genomic analysis of T-PLL provides insights into shared mechanisms of tumor evolution, which have to prove their amenability as targetable lesions.
Authors
- Qu Jiang (ORCID: https://orcid.org/0000-0001-8517-7750)
- Martin Böttcher (ORCID: https://orcid.org/0000-0003-2911-8830)
- Theodoros Georgomanolis (ORCID: https://orcid.org/0000-0002-4066-9257)
- Stéphanie Poulain (ORCID: https://orcid.org/0000-0002-1792-7270)
- Dennis Jungherz
- Alexandra Schrader
- Sanna Timonen (ORCID: https://orcid.org/0000-0002-8139-5950)
- Philipp Bernhard Staber (ORCID: https://orcid.org/0000-0001-6729-7708)
- Tony Andreas Müller (ORCID: https://orcid.org/0000-0002-4139-2392)
- Kerstin Becker (ORCID: https://orcid.org/0009-0009-7897-7181)
- Edith Julia (ORCID: https://orcid.org/0000-0003-3325-8107)
- David Beverungen
- Linus Wahnschaffe
- Julia Bischoff
- Emmanuel Bachy (ORCID: https://orcid.org/0000-0003-2694-7510)
- A. G. Pichler
- Natali Pflug (ORCID: https://orcid.org/0000-0002-3895-7065)
- Tea Pemovska (ORCID: https://orcid.org/0000-0003-2951-4905)
- Till Braun (ORCID: https://orcid.org/0000-0002-0854-7815)
- Marek Franitza
- Thorsten Zenz
- Satu Mustjoki
- Charles Herbaux
- Dimitrios Mougiakakos
- Michael Hallek
- Marco Herling
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- University of Helsinki (FI)
- Inserm (FR)
- University of Cologne (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Zurich (CH)
- Université de Lille (FR)
- Helsinki University Hospital (FI)
- Vienna General Hospital (AT)
- Universitätsklinikum Erlangen (DE)
- Düsseldorf University Hospital (DE)
- Lille’s Cardiology Hospital (FR)
- Comprehensive Cancer Center Vienna (AT)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Integrated Oncology (United States) (US)
- University Hospital of Zurich (CH)
- Hospices Civils de Lyon (FR)
- University Hospital Münster (DE)
- University Hospital Leipzig (DE)
- Institute for Molecular Medicine Finland (FI)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Magdeburg (DE)
- Comprehensive Cancer Center Erlangen (DE)
- University Hospital Cologne (DE)
- Centre International de Recherche en Infectiologie (FR)
- Heinrich Heine University Düsseldorf (DE)
- Medical University of Vienna (AT)
- Leipzig University (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1038/s41467-026-70185-w
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helsingin Yliopisto
- Université de Lille
- Deutsche Forschungsgemeinschaft
- Institut National de la Santé et de la Recherche Médicale
- Bundesministerium für Bildung und Forschung
- Austrian Science Fund
- Universität Wien
- Centre National de la Recherche Scientifique
- José Carreras Leukämie-Stiftung
- Medizinische Universität Wien
- Deutsche Krebshilfe
- Sächsisches Staatsministerium für Wissenschaft und Kunst
- Institut National Du Cancer
- Universität Zürich
- Hospices Civils de Lyon
- Université Claude Bernard Lyon 1
- Universität zu Köln
- Syöpäsäätiö
- Universitätsklinikum Köln
- Helsinki Institute of Life Science, Helsingin Yliopisto